EVO ICL
Commercial- Indications
- Myopia, Hyperopia, Astigmatism
Company intelligence / Profile preview
Staar Surgical’s EVO ICL™ and Visian ICL® family of implantable collamer lenses are approved and marketed globally for the correction of myopia, hyperopia, astigmatism, and cataracts. Over three million lenses have been implanted worldwide with high patient satisfaction (>99%). The company continues to innovate with new models and delivery systems.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Staar Surgical.